骨髓增生 的英文怎麼說

中文拼音 [gǔsuǐzēngshēng]
骨髓增生 英文
bone marrow hyperplasia
  • 骨 : 骨名詞1 （骨頭） bone2 （物體內部的支架） framework; skeleton 3 （品質; 氣概） character; spirit ...
  • 髓 : 名詞1. [生理學] （骨髓; 像骨髓的東西） marrow 2. [植物] （莖的中心部分） pith
  • 生 : Ⅰ動詞1 （生育; 生殖） give birth to; bear 2 （出生） be born 3 （生長） grow 4 （生存; 活） live;...
  • 骨髓 : marrow; keest; medulla ossium; bone marrow骨髓白細胞 myeloplast; 骨髓病 myelopathy; myelopthy; os...
  1. Combined treatment of hyporisky myelodysplasia syndrome with a ndrogen and differentiation inducers

    雄激素聯合分化誘導劑治療低危骨髓增生異常綜合征
  2. Anticancer actiity of this agent has been reported in arious malignant disorders, including multiple myeloma and myelodysplastic syndrome

    它對多種腫瘤具有抗腫瘤活性，其中包括骨髓瘤和骨髓增生異常綜合征。
  3. Such massive splenomegaly is usually indicative of some myeloproliferative disease such as chronic myelogenous leukemia or myelofibrosis

    這樣的脾腫大通常預示有骨髓增生型疾病，例如慢性髓性白血病或骨髓纖維化。
  4. Adequate preoperative fluid hydration, intensive hemodynamic monitoring, ready - prepared blood and vasopressor drugs, inspiration of 100 percent oxygen, and copious irrigation of marrow debris after reaming are useful prophylactic methods to lower the catastrophic complication during cementation

    足夠的術前水分補給，手術中精細的生命徵象監視，隨時準備好的血液及增壓藥物以備不時之需，呼吸純氧以預防低血氧癥，在骨髓腔管被擴鉆后使用大量的水清洗骨髓腔管內的雜質，這些是降低骨水泥心臟血管衰竭並發癥發生的有效方法。
  5. After thymus transplantation, the embryo ' s thymus has trunk cell that comes from the embryo ' s yolk bag, embryo liver and marrow, it excretes a great deal of thymus hormone which change lymphocyte into mature t lymphocyte through multiplication and differentiation, then it help to turn b cell into serous cell, the quantity of the serous cell increases, the antibody that it produces also increases, that is the content of iga, igm and igg is increased

    而移制胎兒胸腺后，由於胎兒胸腺內有來自胎兒卵黃囊、胚肝和骨髓的幹細胞，並能分泌大量胸腺素，促進淋巴細胞在該處增殖、分化為成熟t淋巴細胞，繼而輔助b細胞活化成為漿細胞，漿細胞數量增加，產生的抗體量增加，即igg ， igm ， iga含量增加。
  6. In this report, we mainly covered the following aspects of " tissue organ regeneration and replication in situ " : 1 ) procedures of tissue organd regeneration and replication and replication in clnical practice ; 2 ) the discover and existence of potentiald regenerative cell ( prc ) ; 3 ) the proliferation, differentiation and regeneration law of potential law of potential regenerative cells ; 4 ) study procedure on tissue organ regeneration and replication from prcs in vitro based on the model of full skin organ regeneration in situ after extensive in vitro, set up the method and technology of searching life regenerative substance required in tissue organ regeneration and replication in situ. in this study, first, the whole human body is divided into 206 function units, which are the " tissue organ " in regeneration study. then the histology foundation of tissue organ regeneration and replication in situ is set up. in ordre to prove the existence of the potential regenerative cells and their potential baility and function, we established clinical tracking rechnique of skin organ regeneration in situ ; meanwhile, several tissue organ regeneration and replication in vitro models which represent different kinds of runctions were sucessfully set up, with all these techniques and models, we confirmed : 1 ) the existence, function and ability of pptemtoa regenerative cells ; 2 ) the importance of life regenerative substance ; 3 ) the feasibility of tissue organ regeneration and replication in situ ; 4 ) the big value of tissue organ regeneration and replication in situ in life science and medicine progerss. we also showed the possible foreground of capture cancer with this method and technologh. in this report, nearly 200 photographs of several tissue organ regeneration and replication in situ or in vitro demonstrated the whole process of tissue organ and big organ entities regeneration and replication from cells. the results of tissue organ regeneration and replication in situ mainly include : 1 ) whole skin organ regeneration and replication in situ ; 2 ) gastrointestinal mucosa tissue organ regeneration in vitro ; 3 ) hair follicle tissue organ regeneration in situ or in vitro ; 4 ) never tissue organ regeneration in situ ; 5 ) pancreas tissue organ regeneration and replication in vitro ; 5 ) marrow tissue regeneration in vitro ; 6 ) renal glomerulus and tubule tissue organ tugeneraation in vitro ; 7 ) heart muscle regeneration in vitro, etcl. in order to let more and more people know and understand this technology of tissue organd regeneration and replication in situ, herein, for the first time, we publicize the key points of actualizing this technology. also, we publicized the technology procedures and the frame constitute of life substances. we bilieve this is a big contribution to human science

    本研究報告，重點報道了組織器官的原位再生復制的臨床程序，報道了組織潛能再生細胞的發現和存在，以及該細胞的增殖分化和形成組織器官的變化規律.以燒傷后皮膚組織器官的原位再生復制為模型，研究出了體外組織潛能再生細胞復制組織器官的培養方法;以體外組織器官的復制為模型，建立了尋找原位組織器官再生復制所需生命物質的方法和技術.本研究，首先按人體的器官功能，分解為206個功能單位，確立了所復制的人體器官中的組織功能單位為組織器官，從而建立了原位組織器官再生復制的組織學基礎.為了驗證組織潛能再生細胞的再生潛能，建立了皮膚器官原位再生的實體臨床跟蹤技術，同時又建立了能代表有關器官功能類別的代表組織器官的原位和體外復制模型，以多組織器官的成功復制確定潛能再生細胞的作用，確定生命研究再生物質的重要性，確定組織器官原位再生復制的可行性，確定了組織器官原位再生復制的生命科學研究和醫學進步的重大應用價值，同時展示了用此方法和技術攻克癌癥的前景.本研究報告，以近二百幅多個組織器官原位和體外再生復制的實體圖片，展示了潛能再生細胞復制的組織器官和大器官司實體;展示了細胞再生復制器官的全過程.真實的報告了組織器官原位再生復制的成果.所公布的主要成果為:皮膚器官的原位再生復制;胃腸黏膜組織器官的原位和體外再生復制;毛囊組織器官的原位和體外再生復制;神經組織器官的原位復制;胰腺組織器官的體外復制;骨髓組織的體外復制;腎小球小管組織器官的體外復制;心肌的體外復制等.為了讓更多的人學會和掌握組織器官原位再生復制技術，本報告首次公布實施技術的重要環節和技術流程;首次公布了生命再生物質的框架和組成.作者自費研究成果對人類生命科學的一大貢獻
  7. A spleen > 1000 gm suggests a myeloproliferative, lymphoproliferative, or hematopoietic disorder

    脾大於1000克暗示有骨髓增生、淋巴組織增生或造血系統病變。
  8. Effect of pueraria lobata willd. ohwi on bone marrow proliferation and antibody production of mice

    葛根對小鼠骨髓細胞增殖及抗體產生的研究
  9. Effect of tcm syndrome - typing based therapy combined with cyclosporin in treating myelodysplastic syndrome

    中醫分型論治聯合環孢菌素治療骨髓增生異常綜合征療效初探
  10. Hu zhao, tian - qing liu, ke - dong song, xiang - qin li, xiang - yu sun, xue - hu ma, large - scale expansion of sd rat ' s osteoblasts in rotating wall hollow fiber membrane bioreactor, the 8th tissue engineering society international annual meeting, 2005, oct. 22 - 25, p442, shanghai, china

    王艷芳，劉天慶，宋克東，鮑春雨，李香琴，馬學虎.兔骨髓間充質幹細胞在旋轉壁式生物反應器內的大規模擴增.第二屆全國化學工程與生物化工年會. 2005年10月，北京
  11. Effects of basic fibroblast growth factor and epidermal growth factor on proliferation of bone marrow neural stem cells in rhesus monkey in vitro induction

    表皮生長因子對恆河猴骨髓源性神經幹細胞的體外誘導增殖作用
  12. Myelodysplastic syndrome caused by benzene : a case report

    苯致骨髓增生異常綜合征1例報告
  13. Clinical analysis of myelodysplastic syndrom by benzene

    慢性苯中毒致骨髓增生異常綜合征2例報告
  14. Clinical observation on treating 18 cases of myelodysplastic syndrome with yuduqing

    瘀毒清治療骨髓增生異常綜合征18例臨床觀察
  15. Comparison and analyse fab classification of myelodysplastic syndrome with who classification of myelodysplastic syndrome

    對骨髓增生異常綜合征的分型比較與分析
  16. Using evidence - based guideline for prophylactic platelet transfusion in patient with myelodysplastic syndrome

    以循證指南指導骨髓增生異常綜合征患者預防性血小板輸注
  17. The application of immunocytochemical technique in the bone marrow sections in patients with myelodysplastic syndromes

    免疫組織化學技術在骨髓增生異常綜合征骨髓病理中的應用
  18. A related blood disorder, myelodysplastic syndromes, or mds, occurs when the bone marrow begins producing poorly functioning or immature blood cells. about 20, 000 to 30, 000 new cases occur each year

    骨髓增生異常綜合癥（ mds ）也是一種血液相關的疾病，是由於骨髓產生非成熟或無功能的血細胞。美國每年新發病例大約為20000 - 30000 。
  19. Features of the related myeloproliferative disorder included isolated erythrocytosis, distinctive bone marrow morphology, and reduced serum erythropoietin levels

    相關骨髓增生礙的主要特徵為：獨立的紅細胞增多，特徵性的骨髓心態學以及血清中促紅細胞生成素的減少。
  20. Myeloablative, allogeneic hsct is an effective standard therapy for specific life - threatening diseases, such as leukemia or myelodysplastic syndrome, for which blood cell lineages ( which originate principally in the bone marrow and circulate in the blood ) are abnormal

    骨髓同種異體造血幹細胞移植是治愈某些特殊的危及生命疾病的一種標而準有效的方法，如白血病或骨髓增生異常綜合征，這些疾病的血細胞系（主要來源於骨髓並在外周血中循環）變得異常。
分享友人
分享到 Line

分享到臉書